ECFS 2020 - Optimizing pharmaceutical care in cystic fibrosis

European Cystic Fibrosis Society   303  OPTIMIZING PHARMACEUTICAL CARE IN CYSTIC FIBROSIS CFTR MODULATORS AND PREGNANCY, A CASE STUDY CHAPTER 18 References [1] Edenborough FP, Borgo G, Knoop C, Lannefors L, Mackenzie WE, Madge S, et al. Guidelines for the management of pregnancy in women with cystic fibrosis. J Cyst Fibros. 2008;7 Suppl 1:S2-32. [2] Kroon M, Akkerman-Nijland AM, Rottier BL, Koppelman GH, Akkerman OW, Touw DJ. Drugs during pregnancy and breast feeding in women diagnosed with Cystic Fibrosis - An update. J Cyst Fibros. 2018;17(1):17-25. [3] Taylor-Cousar JL, Jain R., Brown A.W., Nash E.F. Continuation of dual combination CFTR modula- tors during pregnancy in women with cystic fibrosis. J of Cyst Fibros. 2019;18(Suppl. 1):S22. 4 Acknowledgements I would like to express my gratitude towards the two women and their consultants for allowing the use of their medical files and their willingness to answer all my ques- tions with respect to the decisions made. The names of the two women have been changed to protect their anonymity.